TORSEMIDE

TORSEMIDE was reported 33930 times

TORSEMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VASCULAR ANASTOMOTIC HAEMORRHAGE 27 0.9000
1 FEMORAL HERNIA INCARCERATED 33 0.4583
2 THERAPEUTIC DRUG MONITORING ANALYSIS INCORRECTLY PERFORMED 32 0.3368
3 LYMPHATIC FISTULA 32 0.3200
4 VENA CAVA INJURY 29 0.3152
5 NEUROGLYCOPENIA 30 0.2727
6 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 73 0.2475
7 VENTRICULAR ENLARGEMENT 36 0.2045
8 PRODUCT MONITORING ERROR 295 0.2042
9 TRUNCUS ARTERIOSUS PERSISTENT 40 0.2010
10 SYSTEMIC INFECTION 275 0.1658
11 RENAL CYST HAEMORRHAGE 37 0.1637
12 PANCREATIC STEATOSIS 41 0.1507
13 PERIPHERAL CIRCULATORY FAILURE 44 0.1073
14 ABDOMINAL WALL HAEMORRHAGE 26 0.0996
15 WOUND INFECTION PSEUDOMONAS 31 0.0990
16 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 27 0.0891
17 VASCULAR COMPRESSION 27 0.0854
18 LOW CARDIAC OUTPUT SYNDROME 28 0.0838
19 MULTIPLE DRUG THERAPY 59 0.0782
20 HELICOBACTER TEST POSITIVE 40 0.0714
21 DELAYED GRAFT FUNCTION 44 0.0619
22 ORTHOSTATIC INTOLERANCE 44 0.0613
23 HYPERPARATHYROIDISM SECONDARY 148 0.0590
24 LEFT ATRIAL ENLARGEMENT 31 0.0575
25 RESPIRATORY TRACT HAEMORRHAGE 33 0.0553
26 CARDIAC SEPTAL DEFECT 39 0.0542
27 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 75 0.0534
28 AORTIC DILATATION 56 0.0504
29 DEVICE MAINTENANCE ISSUE 29 0.0493
30 CONGENITAL CARDIOVASCULAR ANOMALY 41 0.0489
31 OSTEOCHONDROSIS 56 0.0482
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 51 0.0480
33 CARDIAC FAILURE CHRONIC 201 0.0471
34 CAROTID ARTERIOSCLEROSIS 46 0.0446
35 RENAL ARTERY STENOSIS 59 0.0428
36 NEPHROGENIC ANAEMIA 198 0.0427
37 ARTERIAL HAEMORRHAGE 48 0.0420
38 STASIS DERMATITIS 28 0.0409
39 HYPOCHROMIC ANAEMIA 41 0.0404
40 CARDIAC AMYLOIDOSIS 43 0.0391
41 OBSTRUCTIVE SLEEP APNOEA SYNDROME 56 0.0384
42 HYPERVOLAEMIA 188 0.0380
43 INTERVERTEBRAL DISC SPACE NARROWING 29 0.0360
44 GLOMERULAR FILTRATION RATE INCREASED 29 0.0351
45 GLOMERULAR FILTRATION RATE ABNORMAL 49 0.0346
46 AORTIC ARTERIOSCLEROSIS 87 0.0338
47 RECTAL PROLAPSE 39 0.0323
48 DIVERTICULUM INTESTINAL 137 0.0313
49 TACHYARRHYTHMIA 76 0.0304
50 AORTIC VALVE STENOSIS 54 0.0303
51 WAIST CIRCUMFERENCE INCREASED 31 0.0299
52 DEVICE INFUSION ISSUE 72 0.0290
53 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 256 0.0289
54 DILATED CARDIOMYOPATHY 29 0.0287
55 EJECTION FRACTION ABNORMAL 35 0.0285
56 BRASH SYNDROME 40 0.0285
57 INFUSION SITE DISCHARGE 50 0.0285
58 COR PULMONALE 27 0.0283
59 BRAIN NATRIURETIC PEPTIDE INCREASED 87 0.0282
60 DIASTOLIC DYSFUNCTION 85 0.0275
61 AORTIC VALVE INCOMPETENCE 117 0.0275
62 FOLATE DEFICIENCY 31 0.0268
63 ACUTE PRERENAL FAILURE 31 0.0268
64 INFUSION SITE IRRITATION 34 0.0265
65 INFUSION SITE INDURATION 39 0.0263
66 DYSPNOEA AT REST 76 0.0262
67 HYPERTENSIVE HEART DISEASE 48 0.0256
68 ACTINIC KERATOSIS 66 0.0254
69 INFUSION SITE INFECTION 59 0.0254
70 SEROMA 32 0.0252
71 BLOOD LOSS ANAEMIA 57 0.0251
72 CARDIAC FAILURE ACUTE 167 0.0250
73 ORTHOPNOEA 79 0.0248
74 RIGHT VENTRICULAR FAILURE 169 0.0241
75 LABELLED DRUG-DRUG INTERACTION ISSUE 34 0.0235
76 TRICUSPID VALVE INCOMPETENCE 185 0.0233
77 REBOUND ACID HYPERSECRETION 70 0.0231
78 BRADYARRHYTHMIA 38 0.0231
79 PROCALCITONIN INCREASED 27 0.0230
80 ELECTROCARDIOGRAM ABNORMAL 180 0.0229
81 ATRIOVENTRICULAR BLOCK FIRST DEGREE 99 0.0228
82 INFUSION SITE HAEMORRHAGE 75 0.0228
83 HYPERURICAEMIA 92 0.0224
84 LEFT VENTRICULAR FAILURE 77 0.0223
85 CATHETER SITE DISCHARGE 25 0.0222
86 LEFT VENTRICULAR HYPERTROPHY 94 0.0219
87 PULMONARY ARTERIAL HYPERTENSION 315 0.0217
88 INFUSION SITE PAIN 273 0.0212
89 BLOOD CHOLESTEROL DECREASED 39 0.0209
90 PULMONARY ARTERIAL PRESSURE INCREASED 34 0.0209
91 OXYGEN CONSUMPTION INCREASED 49 0.0205
92 CHRONIC GASTRITIS 46 0.0204
93 SPINAL STENOSIS 84 0.0203
94 END STAGE RENAL DISEASE 368 0.0202
95 ELECTROLYTE IMBALANCE 232 0.0199
96 METABOLIC ALKALOSIS 31 0.0193
97 RALES 112 0.0193
98 INFUSION SITE ERYTHEMA 162 0.0192
99 PULMONARY HYPERTENSION 396 0.0190
100 MITRAL VALVE INCOMPETENCE 215 0.0190
101 SINUS NODE DYSFUNCTION 34 0.0185
102 VENTRICULAR HYPOKINESIA 58 0.0180
103 VENTRICULAR ARRHYTHMIA 66 0.0180
104 BENIGN PROSTATIC HYPERPLASIA 92 0.0178
105 GASTRIC POLYPS 40 0.0177
106 NORMOCYTIC ANAEMIA 26 0.0177
107 HEPATIC CYST 60 0.0177
108 CARDIAC FAILURE 1403 0.0175
109 EXERCISE TOLERANCE DECREASED 99 0.0172
110 MEAN CELL VOLUME INCREASED 44 0.0171
111 HAEMOGLOBIN INCREASED 78 0.0171
112 INFUSION SITE SWELLING 107 0.0170
113 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 86 0.0170
114 DYSPNOEA EXERTIONAL 633 0.0168
115 CATHETER SITE HAEMORRHAGE 42 0.0168
116 FLUID RETENTION 853 0.0168
117 UROSEPSIS 154 0.0167
118 DEVICE CONNECTION ISSUE 35 0.0166
119 VASCULAR DEVICE INFECTION 75 0.0165
120 DUODENITIS 49 0.0160
121 FLUID OVERLOAD 229 0.0157
122 BLOOD UREA INCREASED 262 0.0156
123 PRODUCT PRESCRIBING ERROR 372 0.0156
124 HEPATOSPLENOMEGALY 40 0.0156
125 RENAL CYST 123 0.0155
126 ATRIAL THROMBOSIS 32 0.0155
127 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 63 0.0154
128 RED CELL DISTRIBUTION WIDTH INCREASED 64 0.0154
129 CARDIOVASCULAR INSUFFICIENCY 25 0.0153
130 GLOMERULAR FILTRATION RATE DECREASED 188 0.0153
131 ATRIAL TACHYCARDIA 32 0.0152
132 ATRIAL FLUTTER 121 0.0151
133 ERYSIPELAS 76 0.0151
134 HYPERKALAEMIA 530 0.0151
135 PROTHROMBIN TIME PROLONGED 90 0.0150
136 HYPERPARATHYROIDISM 31 0.0150
137 BLOOD POTASSIUM INCREASED 244 0.0150
138 WHITE BLOOD CELLS URINE POSITIVE 28 0.0149
139 LEFT VENTRICULAR DYSFUNCTION 99 0.0148
140 BLOOD URIC ACID INCREASED 85 0.0147
141 GENERAL PHYSICAL HEALTH DETERIORATION 1689 0.0146
142 INFUSION SITE PRURITUS 46 0.0146
143 COMPLICATIONS OF TRANSPLANTED KIDNEY 33 0.0145
144 CORONARY ARTERY STENOSIS 73 0.0145
145 PARESIS 32 0.0144
146 ISCHAEMIC CARDIOMYOPATHY 44 0.0143
147 HAEMANGIOMA 33 0.0143
148 HYPOPROTEINAEMIA 27 0.0142
149 CHRONIC KIDNEY DISEASE 1032 0.0136
150 OEDEMA PERIPHERAL 1628 0.0133
151 RENAL FUNCTION TEST ABNORMAL 62 0.0133
152 BLOOD CREATINE INCREASED 59 0.0133
153 SUPRAVENTRICULAR EXTRASYSTOLES 45 0.0133
154 TORTICOLLIS 28 0.0132
155 HYPOVOLAEMIA 77 0.0131
156 GASTRITIS EROSIVE 61 0.0131
157 HYPOKALAEMIA 603 0.0131
158 ARTERIOSCLEROSIS CORONARY ARTERY 86 0.0130
159 ANXIETY DISORDER 43 0.0129
160 EJECTION FRACTION DECREASED 198 0.0127
161 INFUSION SITE REACTION 38 0.0127
162 CATHETER SITE ERYTHEMA 27 0.0126
163 FAECALOMA 69 0.0126
164 ACUTE RESPIRATORY FAILURE 240 0.0125
165 DRUG TOLERANCE DECREASED 35 0.0125
166 IRON DEFICIENCY ANAEMIA 115 0.0124
167 POLYURIA 102 0.0124
168 STUPOR 40 0.0124
169 HEART DISEASE CONGENITAL 44 0.0124
170 BLOOD POTASSIUM ABNORMAL 33 0.0124
171 TACHYPNOEA 167 0.0123
172 RENAL FAILURE CHRONIC 94 0.0122
173 INTERNATIONAL NORMALISED RATIO ABNORMAL 42 0.0122
174 ATRIAL FIBRILLATION 1185 0.0122
175 INFLAMMATORY MARKER INCREASED 60 0.0121
176 DIABETIC FOOT 37 0.0121
177 SPINAL OSTEOARTHRITIS 106 0.0121
178 LOWER GASTROINTESTINAL HAEMORRHAGE 89 0.0120
179 ACUTE KIDNEY INJURY 1817 0.0119
180 URINARY TRACT INFECTION BACTERIAL 30 0.0119
181 MICTURITION DISORDER 41 0.0118
182 HIATUS HERNIA 153 0.0118
183 BUNDLE BRANCH BLOCK LEFT 50 0.0118
184 PERIPHERAL VENOUS DISEASE 48 0.0117
185 PULMONARY CONGESTION 154 0.0117
186 ATRIOVENTRICULAR BLOCK COMPLETE 78 0.0116
187 BLOOD PRESSURE SYSTOLIC DECREASED 53 0.0116
188 VENTRICULAR EXTRASYSTOLES 120 0.0115
189 AORTIC STENOSIS 40 0.0115
190 ARTERIOSCLEROSIS 108 0.0115
191 GOUT 205 0.0114
192 ANURIA 98 0.0114
193 VENTRICULAR TACHYCARDIA 187 0.0113
194 SEASONAL ALLERGY 160 0.0113
195 WOUND DEHISCENCE 38 0.0112
196 BREATH SOUNDS ABNORMAL 55 0.0111
197 RENAL IMPAIRMENT 934 0.0111
198 PRURITUS GENITAL 26 0.0110
199 LYMPHOEDEMA 76 0.0110
200 IRON DEFICIENCY 49 0.0109
201 CACHEXIA 56 0.0109
202 CARDIOGENIC SHOCK 156 0.0109
203 DYSLIPIDAEMIA 55 0.0108
204 CONGESTIVE CARDIOMYOPATHY 45 0.0108
205 MELAENA 235 0.0107
206 CONCOMITANT DISEASE AGGRAVATED 65 0.0105
207 LOCALISED OEDEMA 48 0.0104
208 POLYNEUROPATHY 124 0.0103
209 HYPERTENSIVE CRISIS 115 0.0103
210 IMMOBILE 45 0.0103
211 DEVICE POWER SOURCE ISSUE 30 0.0103
212 CATHETERISATION CARDIAC 45 0.0101
213 PERICARDIAL EFFUSION 232 0.0100
214 HYPONATRAEMIA 565 0.0100
215 HYPOTONIA 100 0.0100
216 CARDIAC FAILURE CONGESTIVE 803 0.0100
217 ESCHERICHIA URINARY TRACT INFECTION 42 0.0099
218 OLIGURIA 61 0.0098
219 BUNDLE BRANCH BLOCK RIGHT 45 0.0098
220 BLOOD CREATININE INCREASED 640 0.0098
221 HAEMOTHORAX 28 0.0096
222 HAEMORRHOIDAL HAEMORRHAGE 47 0.0096
223 PLEURAL EFFUSION 585 0.0096
224 AZOTAEMIA 38 0.0095
225 OEDEMA 515 0.0095
226 BLOOD ALBUMIN DECREASED 75 0.0094
227 CARDIOMEGALY 116 0.0094
228 CORONARY ARTERY DISEASE 285 0.0094
229 UPPER GASTROINTESTINAL HAEMORRHAGE 158 0.0094
230 GOITRE 38 0.0093
231 BLOOD CREATININE DECREASED 29 0.0093
232 VARICES OESOPHAGEAL 28 0.0093
233 HAEMORRHAGIC ANAEMIA 40 0.0091
234 ANGINA PECTORIS 258 0.0090
235 BRADYKINESIA 53 0.0090
236 DIZZINESS POSTURAL 87 0.0090
237 HYPERVENTILATION 52 0.0090
238 ASCITES 263 0.0089
239 HAEMATOCHEZIA 493 0.0089
240 CARDIAC PACEMAKER INSERTION 53 0.0089
241 CARDIAC DYSFUNCTION 33 0.0089
242 HAEMATOMA 225 0.0087
243 SQUAMOUS CELL CARCINOMA OF SKIN 52 0.0086
244 FLUID INTAKE REDUCED 43 0.0086
245 BRADYCARDIA 453 0.0085
246 VARICOSE VEIN 44 0.0085
247 PROTEIN TOTAL DECREASED 32 0.0085
248 CARDIOPULMONARY FAILURE 33 0.0085
249 RENAL FAILURE ACUTE 359 0.0085
250 RENAL FAILURE 1118 0.0084
251 GAMMA-GLUTAMYLTRANSFERASE INCREASED 184 0.0083
252 ENTEROCOCCAL INFECTION 40 0.0083
253 SCLERODERMA 30 0.0082
254 LISTLESS 27 0.0082
255 OXYGEN SATURATION DECREASED 460 0.0082
256 HYPERCHOLESTEROLAEMIA 79 0.0082
257 HIGH DENSITY LIPOPROTEIN DECREASED 27 0.0081
258 BLOOD CREATININE ABNORMAL 28 0.0081
259 LARGE INTESTINE POLYP 56 0.0081
260 DERMATITIS CONTACT 92 0.0081
261 HYPERLIPIDAEMIA 96 0.0080
262 NEPHROPATHY 75 0.0080
263 PARKINSONISM 78 0.0080
264 PULMONARY OEDEMA 357 0.0080
265 SNORING 30 0.0079
266 COVID-19 PNEUMONIA 93 0.0079
267 PAIN IN JAW 223 0.0079
268 VENTRICULAR SEPTAL DEFECT 45 0.0079
269 APLASTIC ANAEMIA 41 0.0078
270 ANAEMIA 1478 0.0077
271 CAROTID ARTERY STENOSIS 27 0.0077
272 HYPOTENSION 1545 0.0077
273 WEIGHT FLUCTUATION 80 0.0076
274 HYPOVOLAEMIC SHOCK 36 0.0075
275 CARDIOMYOPATHY 110 0.0074
276 NECROTISING FASCIITIS 26 0.0074
277 TROPONIN INCREASED 56 0.0074
278 GASTROINTESTINAL HAEMORRHAGE 613 0.0073
279 PRODUCT CONTAMINATION 26 0.0073
280 VENTRICULAR FIBRILLATION 81 0.0073
281 GENERALISED OEDEMA 90 0.0073
282 TORSADE DE POINTES 57 0.0073
283 SYNCOPE 726 0.0072
284 ATRIOVENTRICULAR BLOCK 56 0.0072
285 TUBULOINTERSTITIAL NEPHRITIS 135 0.0072
286 HYPERTHYROIDISM 104 0.0072
287 LIPASE INCREASED 55 0.0072
288 OBESITY 114 0.0071
289 C-REACTIVE PROTEIN INCREASED 258 0.0071
290 INGUINAL HERNIA 43 0.0071
291 LACTIC ACIDOSIS 228 0.0070
292 HYPOCALCAEMIA 133 0.0070
293 PROTEIN URINE PRESENT 35 0.0070
294 ARRHYTHMIA 332 0.0070
295 DYSURIA 255 0.0069
296 BLOOD POTASSIUM DECREASED 208 0.0069
297 CATHETER SITE INFECTION 26 0.0069
298 DEHYDRATION 916 0.0069
299 CARDIAC VALVE DISEASE 39 0.0068
300 EPISTAXIS 503 0.0067
301 LUNG INFILTRATION 59 0.0067
302 DIABETIC NEUROPATHY 33 0.0067
303 HEPATIC STEATOSIS 124 0.0067
304 FLANK PAIN 62 0.0066
305 CLOSTRIDIUM DIFFICILE COLITIS 70 0.0066
306 HYPOXIA 231 0.0066
307 HAEMATOCRIT DECREASED 130 0.0065
308 HEPATIC CIRRHOSIS 123 0.0065
309 SINUS BRADYCARDIA 63 0.0065
310 TRANSFUSION 68 0.0065
311 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 338 0.0065
312 CIRCULATORY COLLAPSE 110 0.0065
313 HYPOALBUMINAEMIA 50 0.0064
314 HUMERUS FRACTURE 31 0.0064
315 SPLENOMEGALY 75 0.0064
316 DYSPNOEA 3623 0.0064
317 SUPRAVENTRICULAR TACHYCARDIA 61 0.0064
318 DEMENTIA 178 0.0064
319 HYPERGLYCAEMIA 232 0.0064
320 PRODUCTIVE COUGH 302 0.0063
321 INTERVERTEBRAL DISC DISORDER 27 0.0063
322 RENAL INJURY 187 0.0063
323 DRUG INTERACTION 996 0.0063
324 GROIN PAIN 55 0.0063
325 POLYP 41 0.0063
326 PRESYNCOPE 152 0.0062
327 INTERNATIONAL NORMALISED RATIO INCREASED 178 0.0062
328 BLOOD SODIUM DECREASED 117 0.0062
329 ESCHERICHIA INFECTION 51 0.0062
330 DIVERTICULUM 44 0.0062
331 METABOLIC ACIDOSIS 198 0.0062
332 NOCTURIA 75 0.0062
333 BLOOD THYROID STIMULATING HORMONE DECREASED 28 0.0062
334 SUBDURAL HAEMATOMA 88 0.0061
335 GANGRENE 37 0.0061
336 LUMBAR VERTEBRAL FRACTURE 28 0.0061
337 PULSE ABSENT 29 0.0061
338 PURULENT DISCHARGE 26 0.0061
339 SPRUE-LIKE ENTEROPATHY 30 0.0061
340 MOTOR DYSFUNCTION 62 0.0061
341 URINARY RETENTION 201 0.0060
342 HAEMOGLOBIN DECREASED 617 0.0060
343 NEPHROTIC SYNDROME 41 0.0060
344 SPINAL PAIN 70 0.0060
345 BLOOD PRESSURE DECREASED 396 0.0060
346 URINE OUTPUT DECREASED 52 0.0059
347 HAEMATURIA 202 0.0059
348 HAEMORRHOIDS 115 0.0059
349 ORTHOSTATIC HYPOTENSION 102 0.0059
350 SYNOVIAL CYST 27 0.0058
351 HAEMOPTYSIS 163 0.0058
352 PRODUCT ADMINISTRATION ERROR 118 0.0058
353 HYPERNATRAEMIA 29 0.0058
354 DIABETES MELLITUS INADEQUATE CONTROL 103 0.0058
355 RESPIRATORY FAILURE 424 0.0058
356 RED BLOOD CELL COUNT DECREASED 166 0.0058
357 POSTOPERATIVE WOUND INFECTION 39 0.0058
358 INITIAL INSOMNIA 59 0.0057
359 GASTRITIS 150 0.0057
360 INTERNAL HAEMORRHAGE 65 0.0057
361 STAPHYLOCOCCAL SEPSIS 28 0.0057
362 SHOCK HAEMORRHAGIC 46 0.0056
363 LEUKOCYTOSIS 102 0.0056
364 KIDNEY TRANSPLANT REJECTION 27 0.0056
365 GLYCOSYLATED HAEMOGLOBIN INCREASED 142 0.0056
366 BLOOD CALCIUM DECREASED 63 0.0056
367 ACUTE CORONARY SYNDROME 46 0.0055
368 SUBARACHNOID HAEMORRHAGE 56 0.0055
369 COLITIS MICROSCOPIC 26 0.0055
370 JOINT DISLOCATION 58 0.0055
371 SPUTUM DISCOLOURED 52 0.0055
372 HEPATIC ENCEPHALOPATHY 51 0.0055
373 BLOOD MAGNESIUM DECREASED 47 0.0054
374 VITAMIN D DEFICIENCY 53 0.0054
375 SKIN LACERATION 59 0.0054
376 BASAL CELL CARCINOMA 84 0.0054
377 HOSPICE CARE 53 0.0054
378 TOXIC EPIDERMAL NECROLYSIS 81 0.0053
379 RESTLESSNESS 195 0.0053
380 ACUTE MYOCARDIAL INFARCTION 157 0.0053
381 HYPOMAGNESAEMIA 74 0.0053
382 SERUM FERRITIN INCREASED 28 0.0053
383 BLINDNESS TRANSIENT 39 0.0053
384 DECUBITUS ULCER 43 0.0053
385 ON AND OFF PHENOMENON 29 0.0052
386 DIALYSIS 73 0.0051
387 GASTROENTERITIS 75 0.0051
388 HAEMODYNAMIC INSTABILITY 39 0.0051
389 SWELLING OF EYELID 32 0.0051
390 AMMONIA INCREASED 26 0.0051
391 PYELONEPHRITIS 44 0.0051
392 BLOOD ALKALINE PHOSPHATASE INCREASED 126 0.0051
393 PERIPHERAL SWELLING 780 0.0051
394 RESTLESS LEGS SYNDROME 92 0.0051
395 FALL 1676 0.0050
396 HAEMODIALYSIS 42 0.0050
397 SINUS TACHYCARDIA 71 0.0050
398 CORONAVIRUS INFECTION 33 0.0050
399 MYOPATHY 43 0.0050
400 ECCHYMOSIS 34 0.0050
401 GLUCOSE TOLERANCE IMPAIRED 29 0.0049
402 URINARY INCONTINENCE 145 0.0049
403 PALLOR 133 0.0049
404 COUGH 1369 0.0049
405 SCOLIOSIS 30 0.0048
406 ILEUS 60 0.0048
407 TACHYCARDIA 428 0.0048
408 PRODUCT LEAKAGE 27 0.0048
409 DEVICE RELATED INFECTION 74 0.0048
410 CARDIOVASCULAR DISORDER 122 0.0048
411 RENAL TUBULAR NECROSIS 47 0.0048
412 HYPOGLYCAEMIA 232 0.0048
413 LOW DENSITY LIPOPROTEIN INCREASED 37 0.0048
414 BLOOD BILIRUBIN INCREASED 129 0.0048
415 HAEMATEMESIS 121 0.0048
416 BLOOD PRESSURE DIASTOLIC DECREASED 35 0.0047
417 SLEEP APNOEA SYNDROME 90 0.0047
418 LOCALISED INFECTION 114 0.0047
419 SEPSIS 525 0.0047
420 LYMPHOCYTE COUNT DECREASED 83 0.0047
421 RESPIRATORY TRACT INFECTION 122 0.0047
422 PROTEINURIA 89 0.0047
423 AGRANULOCYTOSIS 87 0.0047
424 DEPRESSED LEVEL OF CONSCIOUSNESS 184 0.0046
425 THERAPY NON-RESPONDER 209 0.0046
426 INCONTINENCE 49 0.0046
427 APNOEA 36 0.0046
428 DEVICE OCCLUSION 65 0.0046
429 SKIN ULCER 119 0.0046
430 HEART RATE IRREGULAR 104 0.0046
431 MUSCLE RIGIDITY 55 0.0046
432 HEPATOMEGALY 45 0.0046
433 LEUKOPENIA 229 0.0046
434 MULTI-ORGAN FAILURE 79 0.0046
435 ATELECTASIS 44 0.0045
436 LOW BIRTH WEIGHT BABY 36 0.0045
437 CARDIAC MURMUR 39 0.0045
438 BLOOD PRESSURE FLUCTUATION 108 0.0045
439 RESPIRATION ABNORMAL 31 0.0045
440 PNEUMONIA ASPIRATION 112 0.0045
441 FACIAL PAIN 40 0.0045
442 HAEMARTHROSIS 40 0.0045
443 URINE ODOUR ABNORMAL 26 0.0044
444 THIRST 79 0.0044
445 BLOOD LACTATE DEHYDROGENASE INCREASED 70 0.0044
446 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45 0.0044
447 HYPOTHYROIDISM 139 0.0043
448 URINARY TRACT INFECTION 740 0.0043
449 CYANOSIS 68 0.0043
450 BLOOD PRESSURE INADEQUATELY CONTROLLED 26 0.0043
451 PANCYTOPENIA 241 0.0043
452 PNEUMONIA 1394 0.0043
453 ERUCTATION 83 0.0043
454 CELLULITIS 216 0.0043
455 SEPTIC SHOCK 186 0.0043
456 DISORIENTATION 169 0.0043
457 GASTRIC ULCER 81 0.0043
458 DUODENAL ULCER 30 0.0042
459 BLOOD THYROID STIMULATING HORMONE INCREASED 39 0.0042
460 RESPIRATORY TRACT CONGESTION 67 0.0042
461 BLOOD IRON DECREASED 50 0.0042
462 VITAMIN D DECREASED 36 0.0042
463 CARDIAC DISORDER 394 0.0042
464 CONJUNCTIVITIS 78 0.0042
465 IMPAIRED HEALING 138 0.0042
466 MICTURITION URGENCY 48 0.0042
467 NEUTROPENIC SEPSIS 30 0.0042
468 HAEMOGLOBIN ABNORMAL 27 0.0042
469 ASPARTATE AMINOTRANSFERASE INCREASED 222 0.0042
470 HYPOTHERMIA 42 0.0041
471 ELECTROCARDIOGRAM QT PROLONGED 148 0.0041
472 QUALITY OF LIFE DECREASED 55 0.0041
473 TUMOUR LYSIS SYNDROME 36 0.0041
474 COAGULOPATHY 68 0.0041
475 PRODUCT ADMINISTRATION INTERRUPTED 32 0.0041
476 BLOOD CREATINE PHOSPHOKINASE INCREASED 117 0.0041
477 CONTRAINDICATED PRODUCT ADMINISTERED 123 0.0041
478 JAUNDICE 109 0.0040
479 RHABDOMYOLYSIS 168 0.0040
480 DIZZINESS 2004 0.0040
481 MYELODYSPLASTIC SYNDROME 58 0.0040
482 LIMB INJURY 108 0.0040
483 PEMPHIGOID 30 0.0040
484 GASTROOESOPHAGEAL REFLUX DISEASE 320 0.0040
485 OSTEOARTHRITIS 168 0.0040
486 PANCREATITIS ACUTE 89 0.0040
487 CYSTITIS 126 0.0040
488 DRY THROAT 40 0.0039
489 WOUND 110 0.0039
490 ABDOMINAL DISTENSION 410 0.0039
491 BRONCHITIS 287 0.0039
492 KETOACIDOSIS 29 0.0039
493 HYDRONEPHROSIS 29 0.0039
494 BRONCHIECTASIS 26 0.0039
495 PELVIC FRACTURE 30 0.0038
496 RENAL DISORDER 179 0.0038
497 CHEST PAIN 711 0.0038
498 ABORTION INDUCED 36 0.0038
499 CLOSTRIDIUM DIFFICILE INFECTION 83 0.0038
500 DECREASED ACTIVITY 41 0.0038
501 RIB FRACTURE 78 0.0038
502 THROMBOCYTOPENIA 424 0.0038
503 THROAT IRRITATION 170 0.0038
504 MYOCARDIAL ISCHAEMIA 43 0.0038
505 VASCULITIS 44 0.0038
506 MALNUTRITION 42 0.0038
507 CHOLESTASIS 72 0.0037
508 DELIRIUM 130 0.0037
509 LARGE INTESTINE PERFORATION 26 0.0037
510 ASPIRATION 41 0.0037
511 LUNG DISORDER 183 0.0037
512 DIVERTICULITIS 103 0.0037
513 PNEUMONIA BACTERIAL 34 0.0037
514 ISCHAEMIC STROKE 66 0.0037
515 POLLAKIURIA 154 0.0037
516 COLD SWEAT 65 0.0037
517 DRUG LEVEL INCREASED 61 0.0037
518 MOUTH HAEMORRHAGE 27 0.0037
519 ABDOMINAL PAIN LOWER 93 0.0037
520 WEIGHT INCREASED 823 0.0037
521 ALANINE AMINOTRANSFERASE INCREASED 225 0.0037
522 DEVICE PHYSICAL PROPERTY ISSUE 28 0.0037
523 HEAD INJURY 115 0.0036
524 BACTERAEMIA 43 0.0036
525 ASTHENIA 1360 0.0036
526 INTERVERTEBRAL DISC PROTRUSION 79 0.0036
527 DEVICE FAILURE 55 0.0036
528 TRANSAMINASES INCREASED 80 0.0036
529 AUTOIMMUNE HEPATITIS 25 0.0036
530 WEIGHT DECREASED 1000 0.0036
531 PULMONARY HAEMORRHAGE 28 0.0036
532 DECREASED APPETITE 829 0.0036
533 MUCOSAL INFLAMMATION 93 0.0035
534 TENDERNESS 37 0.0035
535 NASAL CONGESTION 208 0.0035
536 BLOOD CALCIUM INCREASED 31 0.0035
537 THERAPY PARTIAL RESPONDER 55 0.0035
538 CHOLECYSTITIS 42 0.0035
539 SKIN HAEMORRHAGE 52 0.0035
540 HYPOPHAGIA 89 0.0035
541 OESOPHAGITIS 38 0.0035
542 WOUND INFECTION 38 0.0035
543 FAECES DISCOLOURED 75 0.0035
544 PRODUCT DISTRIBUTION ISSUE 32 0.0034
545 CONSTIPATION 752 0.0034
546 CARDIAC ARREST 284 0.0034
547 BLOOD GLUCOSE ABNORMAL 63 0.0034
548 MYOCARDITIS 39 0.0034
549 MUSCULAR WEAKNESS 386 0.0034
550 CONDITION AGGRAVATED 1029 0.0034
551 EMPHYSEMA 34 0.0034
552 HEART RATE INCREASED 333 0.0034
553 LIVER DISORDER 149 0.0034
554 PRESCRIBED UNDERDOSE 67 0.0034
555 PETECHIAE 35 0.0034
556 GASTROINTESTINAL INFECTION 30 0.0033
557 CHEST DISCOMFORT 342 0.0033
558 DISTURBANCE IN ATTENTION 180 0.0033
559 WHITE BLOOD CELL COUNT INCREASED 128 0.0033
560 DIARRHOEA 2144 0.0033
561 PALPITATIONS 388 0.0033
562 MEDICATION ERROR 184 0.0033
563 MUSCULOSKELETAL PAIN 173 0.0033
564 PLATELET COUNT INCREASED 43 0.0033
565 TYPE 2 DIABETES MELLITUS 111 0.0033
566 OSTEOPENIA 50 0.0033
567 HYPERTENSION 694 0.0033
568 COMPLICATION ASSOCIATED WITH DEVICE 47 0.0032
569 HEPATOTOXICITY 72 0.0032
570 SINUS DISORDER 64 0.0032
571 ANAL INCONTINENCE 29 0.0032
572 PLATELET COUNT DECREASED 342 0.0032
573 PERIPHERAL COLDNESS 44 0.0032
574 PULMONARY FIBROSIS 61 0.0032
575 FULL BLOOD COUNT DECREASED 64 0.0032
576 VERTIGO 193 0.0032
577 UPPER-AIRWAY COUGH SYNDROME 26 0.0032
578 INCREASED TENDENCY TO BRUISE 29 0.0031
579 HEPATIC FAILURE 95 0.0031
580 GAIT INABILITY 105 0.0031
581 UNRESPONSIVE TO STIMULI 81 0.0031
582 SCIATICA 50 0.0031
583 GASTRIC HAEMORRHAGE 36 0.0031
584 HALLUCINATION, VISUAL 66 0.0031
585 PERSONALITY CHANGE 29 0.0031
586 FLATULENCE 177 0.0031
587 LABORATORY TEST ABNORMAL 92 0.0031
588 UPPER RESPIRATORY TRACT INFECTION 143 0.0031
589 BODY HEIGHT DECREASED 33 0.0031
590 ULCER 49 0.0031
591 BLOOD PRESSURE SYSTOLIC INCREASED 60 0.0031
592 BLOOD PRESSURE ABNORMAL 61 0.0031
593 STAPHYLOCOCCAL INFECTION 101 0.0031
594 BLOOD TEST ABNORMAL 43 0.0031
595 CONFUSIONAL STATE 494 0.0031
596 DYSPHAGIA 290 0.0031
597 PERITONITIS 63 0.0030
598 OSTEOMYELITIS 55 0.0030
599 CONTUSION 291 0.0030
600 EAR DISCOMFORT 31 0.0030
601 WHEEZING 179 0.0030
602 POST PROCEDURAL HAEMORRHAGE 35 0.0030
603 HERNIA 58 0.0030
604 HYPERBILIRUBINAEMIA 31 0.0030
605 OSTEOPOROSIS 123 0.0030
606 CHOLELITHIASIS 98 0.0030
607 HEREDITARY ANGIOEDEMA 32 0.0030
608 MULTIPLE ORGAN DYSFUNCTION SYNDROME 84 0.0030
609 FACE OEDEMA 50 0.0030
610 HEART RATE DECREASED 104 0.0030
611 SECRETION DISCHARGE 37 0.0030
612 DRUG ERUPTION 52 0.0029
613 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 28 0.0029
614 ENCEPHALOPATHY 72 0.0029
615 HYPERSOMNIA 84 0.0029
616 SUDDEN DEATH 31 0.0029
617 CORONARY ARTERY OCCLUSION 40 0.0029
618 RETCHING 62 0.0029
619 FRACTURE 55 0.0029
620 FATIGUE 2261 0.0029
621 LOSS OF CONSCIOUSNESS 372 0.0029
622 LIVER FUNCTION TEST INCREASED 62 0.0029
623 BURSITIS 35 0.0029
624 THROMBOSIS 232 0.0029
625 ROTATOR CUFF SYNDROME 37 0.0029
626 SWELLING 268 0.0029
627 CEREBRAL HAEMORRHAGE 102 0.0028
628 MUSCULOSKELETAL DISCOMFORT 49 0.0028
629 AGEUSIA 71 0.0028
630 MOBILITY DECREASED 204 0.0028
631 BLOOD COUNT ABNORMAL 43 0.0028
632 GAIT DISTURBANCE 539 0.0028
633 BEDRIDDEN 37 0.0028
634 LIMB DISCOMFORT 87 0.0028
635 HYPOACUSIS 121 0.0028
636 FEMUR FRACTURE 87 0.0028
637 COGNITIVE DISORDER 131 0.0028
638 SPINAL FRACTURE 56 0.0028
639 DEAFNESS 73 0.0028
640 VOMITING 1312 0.0028
641 FEAR 75 0.0028
642 PYREXIA 960 0.0028
643 DYSSTASIA 81 0.0028
644 FEELING COLD 77 0.0028
645 TREATMENT NONCOMPLIANCE 151 0.0028
646 TRANSIENT ISCHAEMIC ATTACK 93 0.0028
647 HYPERCALCAEMIA 34 0.0028
648 THERAPY CHANGE 27 0.0027
649 SLUGGISHNESS 28 0.0027
650 MENTAL STATUS CHANGES 76 0.0027
651 DIABETES MELLITUS 208 0.0027
652 HEMIPARESIS 46 0.0027
653 DYSARTHRIA 102 0.0027
654 ABSCESS 43 0.0027
655 HYPOKINESIA 39 0.0027
656 MYOCLONUS 32 0.0027
657 NAUSEA 2119 0.0027
658 HAEMORRHAGE 279 0.0027
659 MYOCARDIAL INFARCTION 465 0.0027
660 CEREBRAL INFARCTION 65 0.0027
661 BALANCE DISORDER 229 0.0026
662 CHILLS 310 0.0026
663 ECONOMIC PROBLEM 40 0.0026
664 COVID-19 463 0.0026
665 ATAXIA 31 0.0026
666 HAEMORRHAGE INTRACRANIAL 39 0.0026
667 CANDIDA INFECTION 44 0.0026
668 INFECTION 376 0.0026
669 PAIN IN EXTREMITY 764 0.0026
670 CYTOKINE RELEASE SYNDROME 52 0.0026
671 SINUS CONGESTION 35 0.0026
672 DRY MOUTH 210 0.0026
673 MUSCULOSKELETAL CHEST PAIN 40 0.0026
674 ABDOMINAL PAIN UPPER 532 0.0026
675 ABDOMINAL PAIN 601 0.0026
676 ORAL CANDIDIASIS 34 0.0026
677 MYELOSUPPRESSION 93 0.0026
678 STATUS EPILEPTICUS 29 0.0026
679 AUTOIMMUNE DISORDER 25 0.0026
680 DYSPHONIA 150 0.0026
681 NECK PAIN 143 0.0026
682 HIP FRACTURE 82 0.0025
683 HEADACHE 1597 0.0025
684 RENAL PAIN 27 0.0025
685 NERVE INJURY 28 0.0025
686 TASTE DISORDER 51 0.0025
687 ILLNESS 258 0.0025
688 LOWER LIMB FRACTURE 48 0.0025
689 HERPES ZOSTER 143 0.0025
690 JOINT INJURY 53 0.0025
691 MOUTH ULCERATION 52 0.0025
692 OROPHARYNGEAL PAIN 228 0.0025
693 HALLUCINATION, AUDITORY 39 0.0025
694 DRUG-INDUCED LIVER INJURY 77 0.0025
695 BLOOD PRESSURE INCREASED 374 0.0024
696 LIVER FUNCTION TEST ABNORMAL 71 0.0024
697 RESPIRATORY DISORDER 73 0.0024
698 DYSPEPSIA 240 0.0024
699 GASTROENTERITIS VIRAL 44 0.0024
700 HOSPITALISATION 372 0.0024
701 IMPAIRED GASTRIC EMPTYING 33 0.0024
702 MYALGIA 411 0.0024
703 SKIN LESION 66 0.0024
704 CATARACT 143 0.0024
705 RECTAL HAEMORRHAGE 103 0.0024
706 PRESCRIBED OVERDOSE 46 0.0024
707 BACK PAIN 552 0.0024
708 BLOOD GLUCOSE FLUCTUATION 26 0.0024
709 HEAD DISCOMFORT 42 0.0024
710 RHINORRHOEA 153 0.0024
711 SOMNOLENCE 476 0.0024
712 APHASIA 71 0.0023
713 BLISTER 132 0.0023
714 POST PROCEDURAL COMPLICATION 45 0.0023
715 STEVENS-JOHNSON SYNDROME 52 0.0023
716 RASH MACULO-PAPULAR 52 0.0023
717 ABDOMINAL DISCOMFORT 392 0.0023
718 PLASMA CELL MYELOMA 91 0.0023
719 THERAPY INTERRUPTED 166 0.0023
720 HALLUCINATION 175 0.0023
721 LETHARGY 133 0.0023
722 ALTERED STATE OF CONSCIOUSNESS 50 0.0023
723 PARALYSIS 33 0.0023
724 SHOCK 53 0.0023
725 SCHIZOPHRENIA 28 0.0023
726 NEURALGIA 56 0.0023
727 INTERSTITIAL LUNG DISEASE 111 0.0023
728 SKIN DISCOLOURATION 105 0.0023
729 BLOOD GLUCOSE INCREASED 428 0.0023
730 GINGIVAL BLEEDING 31 0.0023
731 FLUSHING 230 0.0023
732 DEVICE DISLOCATION 98 0.0023
733 BACTERIAL INFECTION 42 0.0022
734 ANOREXIA 29 0.0022
735 PNEUMONITIS 61 0.0022
736 NIGHT SWEATS 72 0.0022
737 INSURANCE ISSUE 34 0.0022
738 PRODUCT USE COMPLAINT 35 0.0022
739 METASTASES TO LIVER 39 0.0022
740 SEDATION 58 0.0022
741 PERICARDITIS 37 0.0022
742 INFLUENZA 243 0.0022
743 DEEP VEIN THROMBOSIS 141 0.0022
744 EOSINOPHILIA 38 0.0022
745 NASOPHARYNGITIS 397 0.0022
746 APHONIA 30 0.0021
747 SINUSITIS 220 0.0021
748 PNEUMOTHORAX 34 0.0021
749 TINNITUS 98 0.0021
750 SKIN DISORDER 71 0.0021
751 SLEEP DISORDER 149 0.0021
752 BRAIN FOG 33 0.0021
753 BACK DISORDER 34 0.0021
754 NEUTROPHIL COUNT DECREASED 85 0.0021
755 PANCREATITIS 110 0.0021
756 COLON CANCER 31 0.0021
757 DIPLOPIA 54 0.0021
758 VIRAL INFECTION 69 0.0021
759 ANKLE FRACTURE 32 0.0021
760 MUSCLE SPASMS 379 0.0021
761 BLOOD GLUCOSE DECREASED 99 0.0021
762 TREMOR 341 0.0021
763 DEATH 1768 0.0021
764 LYMPHOPENIA 29 0.0020
765 DRUG INTOLERANCE 198 0.0020
766 MEMORY IMPAIRMENT 279 0.0020
767 GASTROINTESTINAL DISORDER 181 0.0020
768 PULMONARY EMBOLISM 191 0.0020
769 UPPER LIMB FRACTURE 40 0.0020
770 SNEEZING 45 0.0020
771 FOOT FRACTURE 38 0.0020
772 ANOSMIA 29 0.0020
773 CARPAL TUNNEL SYNDROME 28 0.0020
774 SKIN CANCER 43 0.0020
775 CHROMATURIA 45 0.0020
776 DEPRESSED MOOD 105 0.0020
777 UNEVALUABLE EVENT 150 0.0020
778 DRUG TOXICITY 27 0.0020
779 ANHEDONIA 52 0.0020
780 INFLAMMATION 102 0.0020
781 FEEDING DISORDER 40 0.0020
782 WHITE BLOOD CELL COUNT DECREASED 213 0.0020
783 ARTHRALGIA 816 0.0020
784 THYROID DISORDER 30 0.0019
785 ACCIDENTAL OVERDOSE 71 0.0019
786 KIDNEY INFECTION 38 0.0019
787 SENSORY DISTURBANCE 31 0.0019
788 DISEASE PROGRESSION 228 0.0019
789 CEREBROVASCULAR ACCIDENT 326 0.0019
790 BLOOD TRIGLYCERIDES INCREASED 34 0.0019
791 FUNGAL INFECTION 64 0.0019
792 ARTHRITIS 151 0.0019
793 POOR QUALITY SLEEP 41 0.0019
794 SWELLING FACE 124 0.0019
795 ORAL HERPES 37 0.0019
796 THERAPY CESSATION 97 0.0019
797 CARDIO-RESPIRATORY ARREST 79 0.0019
798 PAIN 1155 0.0019
799 IMPAIRED QUALITY OF LIFE 27 0.0019
800 DEVICE LEAKAGE 81 0.0019
801 HYPOAESTHESIA ORAL 28 0.0019
802 APATHY 27 0.0018
803 RASH PRURITIC 100 0.0018
804 BLOOD URINE PRESENT 35 0.0018
805 NEUROPATHY PERIPHERAL 175 0.0018
806 PRODUCT DOSE OMISSION 120 0.0018
807 MOVEMENT DISORDER 59 0.0018
808 MALAISE 802 0.0018
809 BODY TEMPERATURE INCREASED 37 0.0018
810 RESPIRATORY DISTRESS 50 0.0018
811 SCAR 31 0.0018
812 VISUAL IMPAIRMENT 224 0.0018
813 INTENTIONAL DOSE OMISSION 51 0.0018
814 FEELING ABNORMAL 427 0.0018
815 INSOMNIA 473 0.0018
816 COLITIS 67 0.0018
817 PHOTOSENSITIVITY REACTION 29 0.0018
818 GALLBLADDER DISORDER 31 0.0017
819 EPILEPSY 53 0.0017
820 PRODUCT DOSE OMISSION IN ERROR 49 0.0017
821 HEPATIC FUNCTION ABNORMAL 64 0.0017
822 BONE PAIN 100 0.0017
823 BONE DISORDER 31 0.0017
824 MENTAL DISORDER 74 0.0017
825 LYMPHADENOPATHY 60 0.0017
826 PRURITUS 651 0.0017
827 ERYTHEMA 347 0.0017
828 HYPOAESTHESIA 252 0.0017
829 DEVICE MALFUNCTION 118 0.0017
830 FEELING JITTERY 32 0.0017
831 DEPRESSION 382 0.0017
832 HYPERHIDROSIS 216 0.0017
833 LUNG INFECTION 26 0.0017
834 DYSKINESIA 68 0.0017
835 PRODUCT USE ISSUE 314 0.0017
836 LIVER INJURY 41 0.0017
837 EYE PAIN 94 0.0017
838 EAR INFECTION 44 0.0017
839 ASTHMA 186 0.0016
840 PRODUCT DOSE OMISSION ISSUE 483 0.0016
841 RASH MACULAR 57 0.0016
842 SEIZURE 188 0.0016
843 TOOTH DISORDER 36 0.0016
844 TOXICITY TO VARIOUS AGENTS 271 0.0016
845 MIDDLE INSOMNIA 30 0.0016
846 MUSCLE TIGHTNESS 26 0.0016
847 VISION BLURRED 220 0.0016
848 ILL-DEFINED DISORDER 97 0.0016
849 NERVOUSNESS 83 0.0016
850 DEVICE USE ERROR 55 0.0016
851 MUSCULOSKELETAL DISORDER 30 0.0016
852 STOMATITIS 95 0.0016
853 HEPATITIS 40 0.0016
854 ORAL PAIN 35 0.0016
855 FEELING HOT 95 0.0015
856 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 279 0.0015
857 NEUTROPENIA 210 0.0015
858 EAR PAIN 30 0.0015
859 PHOTOPHOBIA 29 0.0015
860 INTESTINAL OBSTRUCTION 58 0.0015
861 PREMATURE BABY 46 0.0015
862 DRY SKIN 203 0.0015
863 MUSCLE TWITCHING 35 0.0015
864 RASH PAPULAR 34 0.0015
865 ANXIETY 428 0.0015
866 SURGERY 88 0.0015
867 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 72 0.0015
868 ANGIOEDEMA 66 0.0015
869 SPEECH DISORDER 78 0.0015
870 PARAESTHESIA 234 0.0015
871 CHOKING 29 0.0015
872 FIBROMYALGIA 36 0.0015
873 AGITATION 108 0.0015
874 PRODUCT DISPENSING ERROR 32 0.0015
875 BLINDNESS 59 0.0014
876 HEPATIC ENZYME INCREASED 98 0.0014
877 JOINT SWELLING 173 0.0014
878 PRODUCT USE IN UNAPPROVED INDICATION 355 0.0014
879 DISEASE RECURRENCE 68 0.0014
880 INCREASED APPETITE 27 0.0014
881 BLOOD CHOLESTEROL INCREASED 65 0.0014
882 INJURY 98 0.0014
883 OFF LABEL USE 1220 0.0014
884 INCORRECT PRODUCT ADMINISTRATION DURATION 30 0.0014
885 NEPHROLITHIASIS 63 0.0014
886 FEBRILE NEUTROPENIA 91 0.0014
887 PRURITUS GENERALISED 29 0.0013
888 PRODUCT PHYSICAL ISSUE 27 0.0013
889 AMNESIA 87 0.0013
890 MIGRAINE 127 0.0013
891 NIGHTMARE 46 0.0013
892 HOT FLUSH 100 0.0013
893 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 268 0.0013
894 SUICIDE ATTEMPT 80 0.0013
895 EYE SWELLING 49 0.0013
896 RASH 569 0.0013
897 NEOPLASM MALIGNANT 87 0.0013
898 MUSCULOSKELETAL STIFFNESS 114 0.0013
899 FREQUENT BOWEL MOVEMENTS 35 0.0013
900 LACRIMATION INCREASED 39 0.0013
901 INTENTIONAL PRODUCT USE ISSUE 111 0.0013
902 RHEUMATOID ARTHRITIS 143 0.0013
903 IRRITABLE BOWEL SYNDROME 27 0.0013
904 UNDERDOSE 91 0.0012
905 DERMATITIS 26 0.0012
906 MENTAL IMPAIRMENT 30 0.0012
907 KNEE ARTHROPLASTY 26 0.0012
908 PANIC ATTACK 45 0.0012
909 INCORRECT DOSE ADMINISTERED 280 0.0012
910 DEVICE ISSUE 110 0.0012
911 PAIN OF SKIN 33 0.0012
912 EATING DISORDER 26 0.0012
913 SKIN EXFOLIATION 103 0.0012
914 EYE PRURITUS 41 0.0012
915 PHARMACEUTICAL PRODUCT COMPLAINT 31 0.0012
916 ARTHROPATHY 66 0.0012
917 DISCOMFORT 72 0.0012
918 COMA 56 0.0012
919 DYSGEUSIA 87 0.0012
920 THERAPEUTIC RESPONSE UNEXPECTED 52 0.0012
921 SWOLLEN TONGUE 36 0.0012
922 RASH ERYTHEMATOUS 55 0.0011
923 ROAD TRAFFIC ACCIDENT 48 0.0011
924 MALIGNANT NEOPLASM PROGRESSION 115 0.0011
925 VISUAL ACUITY REDUCED 37 0.0011
926 LIP SWELLING 37 0.0011
927 JOINT STIFFNESS 29 0.0011
928 NEOPLASM PROGRESSION 38 0.0011
929 ALOPECIA 214 0.0011
930 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 28 0.0011
931 INFLUENZA LIKE ILLNESS 89 0.0011
932 GASTRIC DISORDER 37 0.0011
933 BURNING SENSATION 75 0.0011
934 INTENTIONAL OVERDOSE 68 0.0011
935 NERVOUS SYSTEM DISORDER 33 0.0011
936 ANAPHYLACTIC SHOCK 27 0.0010
937 DRY EYE 52 0.0010
938 LUNG NEOPLASM MALIGNANT 42 0.0010
939 RESPIRATORY ARREST 28 0.0010
940 ECZEMA 53 0.0010
941 ERECTILE DYSFUNCTION 26 0.0010
942 ADVERSE DRUG REACTION 90 0.0010
943 EXTRA DOSE ADMINISTERED 40 0.0010
944 DEVICE BREAKAGE 40 0.0010
945 OVERDOSE 212 0.0010
946 OSTEONECROSIS 32 0.0010
947 ADVERSE EVENT 88 0.0010
948 INJECTION SITE PRURITUS 63 0.0009
949 HYPERSENSITIVITY 171 0.0009
950 EYE IRRITATION 53 0.0009
951 EMOTIONAL DISTRESS 111 0.0009
952 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 50 0.0009
953 URTICARIA 152 0.0009
954 OCULAR HYPERAEMIA 43 0.0009
955 GYNAECOMASTIA 28 0.0009
956 SYSTEMIC LUPUS ERYTHEMATOSUS 32 0.0009
957 LOWER RESPIRATORY TRACT INFECTION 40 0.0009
958 EYE DISORDER 28 0.0009
959 INFUSION RELATED REACTION 56 0.0008
960 AGGRESSION 40 0.0008
961 DRUG DOSE OMISSION 131 0.0008
962 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 56 0.0008
963 INTENTIONAL PRODUCT MISUSE 68 0.0008
964 CONVULSION 44 0.0008
965 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 53 0.0007
966 IRRITABILITY 44 0.0007
967 DRUG INEFFECTIVE 960 0.0007
968 PSORIATIC ARTHROPATHY 29 0.0007
969 COMPLETED SUICIDE 59 0.0007
970 ANAPHYLACTIC REACTION 39 0.0007
971 FOETAL EXPOSURE DURING PREGNANCY 57 0.0007
972 MULTIPLE SCLEROSIS 32 0.0007
973 INJECTION SITE BRUISING 53 0.0007
974 THERAPEUTIC PRODUCT EFFECT DECREASED 29 0.0006
975 INJECTION SITE ERYTHEMA 79 0.0006
976 DEVICE DIFFICULT TO USE 42 0.0006
977 ACNE 48 0.0006
978 VAGINAL HAEMORRHAGE 27 0.0006
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29 0.0006
980 INJECTION SITE HAEMORRHAGE 49 0.0006
981 PSORIASIS 80 0.0006
982 SUICIDAL IDEATION 52 0.0006
983 DRUG ABUSE 45 0.0005
984 PRODUCT QUALITY ISSUE 72 0.0005
985 THERAPEUTIC RESPONSE DECREASED 32 0.0005
986 INJECTION SITE PAIN 160 0.0005
987 INJECTION SITE SWELLING 39 0.0005
988 PRODUCT SUBSTITUTION ISSUE 27 0.0005
989 MATERNAL EXPOSURE DURING PREGNANCY 41 0.0005
990 PROSTATE CANCER 36 0.0004
991 SKIN BURNING SENSATION 32 0.0004
992 ACCIDENTAL EXPOSURE TO PRODUCT 46 0.0004
993 BREAST CANCER 41 0.0004
994 DRUG DEPENDENCE 56 0.0003
995 NO ADVERSE EVENT 49 0.0003